OTHER APPLICATIONS

Melanoma
Skin cancer is the most common cancer in the United States. The incidence of melanoma, the rarest but most virulent form of skin cancer, is increasing at the rate of 7% a year. Skin cancers are often treated by excisional biopsy, if diagnosed early. ODIS can be used to facilitate early identification and reduce unnecessary biopsies.

Breast Cancer
Breast cancer is the most common malignancy and one of the leading causes of death in women. Despite advances in digital mammography, diagnosis of breast cancer continues to be plagued with a very high false positive rate, thus creating a controversy about the real value of mammography. The US healthcare system spends $5 billion annually on x-ray mammograms each year. About one million women in the US are recalled for biopsy, which turns out to be negative in 65% to 80% of the cases. ODIS has powerful diagnostic capabilities and can provide a valuable adjunct to mammography. This will lead to a reduction in unnecessary biopsies and earlier intervention in malignant cases.

Neonatology
470,000 premature infants per year in the US face respiratory distress, oxygen-related blindness, necrotizing enterocolitis, and brain hemorrhage. ODIS can monitor oxygen at specific organ sites, perform accurate measurements at low levels and aid in early intervention in high risk cases. ODISsey can provide simple, cost-effective monitoring that helps improve outcomes and reduce cost.

Note: Some of the applications discussed in the Application and Future Applications section are for research purposes only.